Serum Fibroblast Growth Factor-23 Levels and Progression of Aortic Arch Calcification in Non-Diabetic Patients on Chronic Hemodialysis
Authors:
Open Access
- 1 January 2011
- journal article
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 18 (3) , 217-223
Abstract
Aim: Vascular calcification is a cause of cardiovascular death in hemodialysis (HD) patients. The aim of the present study was to evaluate the relationship between the progression of aortic arch calcification (AoAC) and serum fibroblast growth factor (FGF)-23. Methods: The enrolled study subjects were 127 (83 men and 44 women) HD patients. Calcification of the aortic arch was semiquantitatively estimated with a score (AoACS) on plain chest radiology. Change in AoACS (ΔAoACS) was obtained by subtracting the baseline AoACS value from the follow-up AoACS value. The second assessment was performed from 5 years after the first determination. Results: The percentage of male gender in non-progressors (58.5%) was lesser than in regressors (60.0%) and progressors (74.6%). In addition, the dialysis duration in regressors (14.1±5.1 years) was shorter than in non-progressors (19.5±7.0 years) and progressors (16.8±7.5 years). Interestingly, the serum FGF-23 level in regressors (39225.5±9247.9 pg/mL) was significantly higher than in non-progressors (12896.5±26323.5 pg/mL) and progressors (14062.4±18456.8 pg/mL). Multi-ple regression analyses showed male gender (β value=0.969, F=5.092, p=0.0192), serum levels of albumin (β value=−1.395, F=4.541, p=0.0296) and log FGF-23 (β value=−0.001, F=7.273, p=0.0115) to be significant independent determinants of ΔAoACS. Conclusion: Changes in AoAC evaluated by using a simple chest radiograph are associated with serum FGF-23 levels. Excess accumulation of FGF-23 in serum may enable to inhibit the calcification process in vessel walls in chronic HD patients.Keywords
This publication has 33 references indexed in Scilit:
- Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patientsNephrology Dialysis Transplantation, 2010
- Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patientsHemodialysis International, 2009
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney DiseaseCirculation, 2009
- Mechanism of Pi-induced Vascular Calcification - Regulation of Growth Arrest-Specific Gene 6 (Gas6)-Mediated Survival PathwayJournal of Atherosclerosis and Thrombosis, 2008
- Vitamin D levels and early mortality among incident hemodialysis patientsKidney International, 2007
- Vascular CalcificationsJournal of the American Society of Nephrology, 2006
- Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis PatientsTherapeutic Apheresis and Dialysis, 2005
- Vascular calcification in the uremic patient: A cardiovascular risk?Kidney International, 2003
- Cardiac calcification in adult hemodialysis patientsJACC, 2002
- Aortic calcified plaques and cardiovascular disease (the Framingham study)The American Journal of Cardiology, 1990